Dry powder inhalation formulation of chitosan nanoparticles for co-administration of isoniazid and pyrazinamide
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dry powder inhalation formulation of chitosan nanoparticles for co-administration of isoniazid and pyrazinamide
Authors
Keywords
-
Journal
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
Volume 26, Issue 2, Pages 181-192
Publisher
Informa UK Limited
Online
2020-11-20
DOI
10.1080/10837450.2020.1852570
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers
- (2020) Ruhisy Mohd Rasul et al. CARBOHYDRATE POLYMERS
- EGFR-targeted photodynamic therapy by curcumin-encapsulated chitosan/TPP nanoparticles
- (2018) Wen-Hsuan Tsai et al. International Journal of Nanomedicine
- Development and evaluation of Chitosan nanoparticles based dry powder inhalation formulations of Prothionamide
- (2018) Sujit Kumar Debnath et al. PLoS One
- Chitosan nanoparticles as a promising approach for pulmonary delivery of bedaquiline
- (2018) Tejal Rawal et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Exploring inhalable polymeric dry powders for anti-tuberculosis drug delivery
- (2018) Margarida S. Miranda et al. Materials Science & Engineering C-Materials for Biological Applications
- Tratamiento de la enfermedad tuberculosa pulmonar y extrapulmonar
- (2017) José Francisco Pascual-Pareja et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Dry powder inhalable formulations for anti-tubercular therapy
- (2016) Thaigarajan Parumasivam et al. ADVANCED DRUG DELIVERY REVIEWS
- Autophagy in Pulmonary Diseases
- (2016) Kiichi Nakahira et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Drug-Resistant Tuberculosis
- (2016) Sebastian G. Kurz et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Influence of physical properties of carrier on the performance of dry powder inhalers
- (2016) Tingting Peng et al. Acta Pharmaceutica Sinica B
- Preparation of chitosan–TPP nanoparticles using microengineered membranes – Effect of parameters and encapsulation of tacrine
- (2015) S. Hassani et al. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
- Pulmonary drug delivery systems for tuberculosis treatment
- (2015) Dinh-Duy Pham et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis
- (2015) Kwonjune J. Seung et al. Cold Spring Harbor Perspectives in Medicine
- Host Cell Autophagy Activated by Antibiotics Is Required for Their Effective Antimycobacterial Drug Action
- (2012) Jwa-Jin Kim et al. Cell Host & Microbe
- Preparation and evaluation of the effect of particle size on the properties of chitosan-montmorillonite nanoparticles loaded with isoniazid
- (2012) Nibedita Banik et al. RSC Advances
- Isoniazid Proliposome Powders for Inhalation—Preparation, Characterization and Cell Culture Studies
- (2011) Wipaporn Rojanarat et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Physicochemical Characterization and Stability of Rifampicin Liposome Dry Powder Formulations for Inhalation
- (2008) Narumon Changsan et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started